Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SASU MULTIPHARM : revenue, balance sheet and financial ratios

SASU MULTIPHARM is a French company founded 10 years ago, specialized in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques. Based in SION-LES-MINES (44590), this company of category PME shows in 2023 a net income positive of 199 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SASU MULTIPHARM (SIREN 818430993)
Indicator 2023
Revenue N/C
Net income 199 368 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2023, SASU MULTIPHARM generates positive net income of 199 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

199 368 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

6.361%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

62.828%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

86.3%

Solvency indicators evolution
SASU MULTIPHARM

Sector positioning

Debt ratio
6.36 2023
2023
Q1: 0.0
Med: 7.74
Q3: 43.88
Good

In 2023, the debt ratio of SASU MULTIPHARM (6.36) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
62.83% 2023
2023
Q1: 12.27%
Med: 40.31%
Q3: 63.81%
Good

In 2023, the financial autonomy of SASU MULTIPHARM (62.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 234.65. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

234.651

Liquidity indicators evolution
SASU MULTIPHARM

Sector positioning

Liquidity ratio
234.65 2023
2023
Q1: 143.48
Med: 239.57
Q3: 444.35
Average

In 2023, the liquidity ratio of SASU MULTIPHARM (234.65) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SASU MULTIPHARM in its sector

Comparison with sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Valuation estimate

Based on 50 transactions of similar company sales (all years), the value of SASU MULTIPHARM is estimated at 319 853 € (range 223 023€ - 1 097 864€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2023
50 tx
223k€ 319k€ 1097k€
319 853 € Range: 223 023€ - 1 097 864€
NAF 5 all-time

Valuation method used

Net Income Multiple
199 368 € × 1.6x = 319 854 €
Range: 223 023€ - 1 097 865€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 50 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Intermédiaires spécialisés dans le commerce d'autres produits spécifiques)

Compare SASU MULTIPHARM with other companies in the same sector:

Voir toutes les statistiques du secteur Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Frequently asked questions about SASU MULTIPHARM

What is the revenue of SASU MULTIPHARM ?

The revenue of SASU MULTIPHARM is not publicly disclosed (confidential accounts filed with INPI).

Is SASU MULTIPHARM profitable?

Yes, SASU MULTIPHARM generated a net profit of 199 k€ in 2023.

Where is the headquarters of SASU MULTIPHARM ?

The headquarters of SASU MULTIPHARM is located in SION-LES-MINES (44590), in the department Loire-Atlantique.

Where to find the tax return of SASU MULTIPHARM ?

The tax return of SASU MULTIPHARM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SASU MULTIPHARM operate?

SASU MULTIPHARM operates in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques (NAF code 46.18Z). See the 'Sector positioning' section above to compare the company with its competitors.